BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 14, 2002
View Archived Issues
TRK-820 as a pharmacotherapeutic for cocaine addiction
Read More
A once-daily dose regimen of NN-2211 found to be feasible for NIDDM
Read More
Intimatan superior to dalteparin in canine model of vessel wall injury thrombosis
Read More
Bio-Technology General offers second-quarter progress report
Read More
Bicifadine as effective as codeine in treating moderate to severe postsurgical dental pain
Read More
Vitex and Pall modify Inactine collaboration
Read More
Phase III results for Provenge in prostate cancer
Read More
Enrollment completed in phase II HspE7 trial
Read More
Essential Therapeutics and Fujisawa collaborate on antibiotic drug discovery
Read More
Clearance given for FM-VP4 trial
Read More
Avanir and Medison sign research and marketing agreement for Neurodex in Israel
Read More
ANO-2, a novel cyclic peroxide, shows multifunctional antiangiogenic and antitumor activity
Read More
Doxycycline inhibits abdominal aortic aneurysm growth
Read More
FDA approves Eloxatin for advanced colorectal cancer
Read More
Proneuron expands recruitment in macrophage therapy phase I trial in spinal cord injury
Read More
INS-37217 Intranasal improves multiple perennial allergic rhinitis symptoms in phase II trial
Read More
AstraZeneca researchers identify new IBAT inhibitors for dyslipidemic conditions
Read More
New antibacterial and antiprotozoal compounds claimed by De Novo
Read More
Novel antirhinoviral compounds prepared and tested at Biota
Read More
Novel NMDA receptor antagonists disclosed in patent
Read More
Novel EGFR inhibitors in early development at Boehringer Ingelheim
Read More